Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub

Accomplished female scientists at Novartis share their wisdom born from difficult moments in life.

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Accelerating Research to Get Answers Faster

Lazala has been recognized by Hispanic Executive magazine for her commitment to mentoring students and colleagues.

Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.